Thank you everybody for taking part to “Can’t stop the future”, the conference organized
by IMA Active dedicated to the latest developments in the field of Continuous Manufacturing
with speakers representatives from FDA, MIT, ISPE, CONTINUUS Pharmaceuticals,
Patheon, Johnson & Johnson, Teva, Emerson, Colorcon.
The event was broadcasted in Live Streaming on IMA TV
and starting from now every speech is available on demand.
List of interventions
Control strategies for continuous manufacturing
Alan Johnston is Senior Life Sciences Consultant at Emerson’s Global consultancy team. He has spent a majority of his career in the Life Sciences industry with a broad range of technical and business experience across production, automation and digitalization including Primary, Secondary and Vaccine manufacture. He has previously held senior technical roles at Siemens, Novartis Vaccines and GSK.
How to implement and validate continuous manufacturing of direct compression tablets: challenges and opportunities
Frank Streil is Director Technical and Scientific Aairs at Teva/RATIOPHARM. His main interests and experience are in the field of process development and validation as well as in new technologies, PAT and Continuous Manufacturing.
Making the switch from batch to continuous manufacturing: an industrial perspective
Giustino Di Pretoro
Giustino Di Pretoro is Associate Director at Janssen Pharmaceutica, a Johnson & Johnson Company. He is a subject matter expert and drug product development lead for Continuous Manufacturing, and coordinator for a series of academic collaborations within the field of continuous.
Dynamic process models for continuous encapsulation processes
September 27, 2019 - 09:00 am
Keirnan LaMarche is Senior Principal Scientist at Patheon. He is an expert in solid dosage form design, continuous manufacturing, and he received his PhD in chemical Engineering from Rutgers University in 2008. He gained 10 years of experience in solid dosage form development at Bristol-Myers Squibb.
Integrated continuous manufacturing with new technologies: pilot plant implementation
Salvatore Mascia is the Founder and CEO of CONTINUUS Pharmaceuticals. He was the former Strategic Project Manager at the Novartis-MIT Center for Continuous Manufacturing, where he led the integration of the first end-to-end Continuous Manufacturing process for pharmaceuticals.
Guia Bertuzzi is Product Manager at IMA Active division since 2005. She has been working in mixing, granulation and powders handling systems for more than 20 years. She is expert in pharmaceutical engineering and process for Active Pharmaceutical Ingredients and Oral Solid Dosage forms.
Global regulatory implementation on continuous manufacturing
Moheb M. Nasr
Moheb M. Nasr managed the CDER Pharmaceutical Analysis Program at the US FDA for four years and had the lead of the CDER/FDA CMC Regulatory Program for more than eight years. He also worked for GSK as VP Global CMC Strategy. In 2018 he started his own consultancy business.
Continuous manufacturing: state of the art, challenges, and future prospects
Bernhardt L. Trout
Bernhardt L. Trout is Professor of Chemical Engineering at MIT and Director of Novartis-MIT Center for Continuous Manufacturing. His research focuses on the development of advanced manufacturing processes and rational tools for formulation and product design.